Nirmatrelvir for Nonhospitalized Adults with Covid-19. Reply
N Engl J Med
.
2022 Aug 4;387(5):475-476.
doi: 10.1056/NEJMc2206277.
Epub 2022 Jul 20.
Authors
Jennifer Hammond
1
,
Weihang Bao
2
,
Abraham Simón-Campos
3
Affiliations
1
Pfizer, Collegeville, PA
[email protected]
.
2
Pfizer, New York, NY.
3
Köhler and Milstein Research, Mérida, Mexico.
PMID:
35857649
DOI:
10.1056/NEJMc2206277
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
COVID-19*
Hospitalization
Humans
SARS-CoV-2